全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Acute Phase Response and Neutrophils?:?Lymphocyte Ratio in Response to Astaxanthin in Staphylococcal Mice Mastitis Model

DOI: 10.1155/2014/147652

Full-Text   Cite this paper   Add to My Lib

Abstract:

The purpose of the study was to determine the immunotherapeutic effect of astaxanthin (AX) on total clinical score (TCS), C-reactive protein (CRP), and neutrophil?:?lymphocyte ratio in mice mastitis model challenged with pathogenic Staphylococcus aureus. Twenty-four lactating mice were divided in 4 equal groups: group I mice served as normal healthy control, group II, positive control, were challenged with pathogenic S. aureus, group III mice were challenged and treated with AX, and group IV were treated with amoxicillin plus sulbactum. The TCS was higher in postchallenged mice; however it was significantly higher in group II untreated mice as compared to group III and group IV mice. The neutrophil was higher and lymphocyte count was lower in group II mice at 120 hrs post challenge (PC). The CRP was positive in all the challenged group at 24 hrs PC, but it remained positive till 120 hrs PC in group II. The parameters are related to enhancement of the mammary defense and reduction of inflammation. Hence AX may be used alone or as an adjunct therapy with antibiotic for amelioration of mastitis. Development of such therapy may be useful to reduce the antibiotic burden in management of intramammary infection. 1. Introduction Bovine mastitis is the inflammation of the mammary gland frequently resulting from Staphylococcus aureus colonization in the mammary parenchyma causing high economic losses despite intensive research and preventive measures [1]. In vitro antibacterial sensitivity of commonly used antibioticswas demonstrated by several researchers for S. aureus isolates [2]; however the pathogen remains difficult to eradicate with the available antibiotics. Failure in treatment could be due to nonavailability or weak penetration of the antibiotics as the organism survives intracellularly. The greatest demerits of antibiotic treatment are the development of multiple drug resistant bacterial strains and residues in the milk which possess human health hazard. World Health Organization [3] emphasizes need of judicial use of antimicrobials to combat antimicrobial resistance and also to encourage the development of novel preventive and therapeutic aids. Hence search is going on globally for an alternative to antibiotic, or to reduce its dose and duration for therapy. Astaxanthin (AX) is a xanthophyll carotenoid, predominantly of marine origin and naturally obtained from the chlorophyte algae Haematococcus pluvialis [4]. Astaxanthin is a highly potent antioxidant apart from it, it anti-inflammatory, immunomodulatory and antibacterial activities [5–8].

References

[1]  S. Taponen and S. Py?r?l?, “Coagulase-negative staphylococci as cause of bovine mastitis-Not so different from Staphylococcus aureus?” Veterinary Microbiology, vol. 134, no. 1-2, pp. 29–36, 2009.
[2]  D. C. Oliveira, S. W. Wu, and H. De Lencastre, “Genetic organization of the downstream region of the mecA element in methicillin-resistant Staphylococcus aureus isolates carrying different polymorphisms of this region,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 7, pp. 1906–1910, 2000.
[3]  WHO, Antimicrobial resistance: global report on surveillance, 2014, http://www.who.int/drugresistance/en/.
[4]  M. Olaizola and M. E. Huntley, “Recent advances in commercial production of astaxanthin from microalgae,” in Biomaterials and Bioprocessing, M. Fingerman and R. Nagabhushanam, Eds., Science Publishers, 2003.
[5]  Y. Ikeda, S. Tsuji, A. Satoh, M. Ishikura, T. Shirasawa, and T. Shimizu, “Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells,” Journal of Neurochemistry, vol. 107, no. 6, pp. 1730–1740, 2008.
[6]  M. Bennedsen, X. Wang, R. Willén, T. Wadstr?m, and L. P. Andersen, “Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes,” Immunology Letters, vol. 70, no. 3, pp. 185–189, 2000.
[7]  H. Kurihara, H. Koda, S. Asami, Y. Kiso, and T. Tanaka, “Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress,” Life Sciences, vol. 70, no. 21, pp. 2509–2520, 2002.
[8]  U. Kumari and R. Ramanujan, “Isolation of astaxanthin from shrimp metapenaeus dobsoni and study of its pharmacological activity,” Journal of Current Chemical and Pharmaceutical Science, vol. 3, no. 1, pp. 60–63, 2013.
[9]  NCCLS, “Performance standards for antimicrobial susceptibility testing, 9th informational supplements,” Document M100-S9, NCCLS, Wayne, Pa, USA, 1999, (vol. 19, no. 1, Table 21).
[10]  L. A. Chitwood, “Tube dilution antimicrobial susceptibility testing: efficacy of a microtechnique applicable to diagnostic laboratories,” Applied Microbiology, vol. 17, no. 5, pp. 707–709, 1969.
[11]  J. H. Jorgensen, “Selection criteria for an antimicrobial susceptibility testing system,” Journal of Clinical Microbiology, vol. 31, no. 11, pp. 2841–2844, 1993.
[12]  O. W. Schalm and D. O. Noorlander, “Experiments and observations leading to development of the California mastitis test,” Journal of the American Veterinary Medical Association, vol. 130, no. 5, pp. 199–204, 1957.
[13]  T. K. Griffin, F. H. Dodd, F. K. Neave, D. R. Westgarth, R. G. Kingwil, and C. D. Wilson, “A method of diagnosing intramammary infection in dairy cows for large experiments,” Journal of Dairy Research, vol. 44, no. 1, pp. 25–45, 1977.
[14]  R. Cruickshank, Mackie and Mc Cartney's Handbook of Bacteriology, E & S.Livingstone limited, Edinburgh, UK, 10th edition, 1962.
[15]  A. A. Miles, S. S. Misra, and J. O. Irwin, “The estimation of the bactericidal power of the blood,” The Journal of Hygiene, vol. 38, no. 6, pp. 732–749, 1938.
[16]  Sridevi, Studies on isolation, characterization and therapeutic use of bacteriophages against Streptococcus agalactiae associated with ruminant mastitis [M.V.Sc. thesis], Indian Veterinary Research Institute, Izatnagar, India, 2005.
[17]  N. C. Jain, Schalm's Veterinary Hematology, Lea and Febrriger, Philadelphia, Pa, USA, 4th edition, 1986.
[18]  R. Mukherjee, G. C. Ram, P. K. Dash, and T. Goswami, “The activity of milk leukocytes in response to a water-soluble fraction of Mycobacterium phlei in bovine subclinical mastitis,” Veterinary Research Communications, vol. 28, no. 1, pp. 47–54, 2004.
[19]  R. Mukherjee, P. K. Dash, and G. C. Ram, “Immunotherapeutic potential of Ocimum sanctum (L) in bovine subclinical mastitis,” Research in Veterinary Science, vol. 79, no. 1, pp. 37–43, 2005.
[20]  S. Goto, K. Kogure, K. Abe et al., “Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin,” Biochimica et Biophysica Acta, vol. 1512, no. 2, pp. 251–258, 2001.
[21]  K.-E. Eilertsen, H. K. M?hre, I. J. Jensen et al., “A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice,” The Journal of Nutrition, vol. 142, no. 3, pp. 508–512, 2012.
[22]  S.-J. Lee, S.-K. Bai, K.-S. Lee, et al., “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation,” Molecules and Cells, vol. 16, no. 1, pp. 97–105, 2003.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133